CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-04 | San Martin Javier Chief Medical Officer | Grant or award | +60,000 | 151,500 | ||
| 2023-01-04 | Myszkowski Kenneth Allen Chief Financial Officer | Grant or award | +60,000 | 396,704 | ||
| 2023-01-04 | O'Brien Patrick COO and General Counsel | Grant or award | +65,000 | 428,375 | ||
| 2023-01-04 | Hamilton James C Chief Discovery/Trans Medicine | Grant or award | +60,000 | 205,287 | ||
| 2023-01-03 | O'Brien Patrick COO and General Counsel | Sale | −2,653 | $37.53 | $100K | 378,222 |
| 2023-01-03 | O'Brien Patrick COO and General Counsel | Sale | −5,527 | $38.54 | $213K | 372,695 |
| 2023-01-03 | O'Brien Patrick COO and General Counsel | Sale | −500 | $39.74 | $20K | 372,195 |
| 2023-01-03 | O'Brien Patrick COO and General Counsel | Sale | −70 | $40.80 | $3K | 372,125 |
| 2023-01-03 | O'Brien Patrick COO and General Counsel | Sale | −2,894 | $37.58 | $109K | 369,231 |
| 2023-01-03 | O'Brien Patrick COO and General Counsel | Sale | −5,286 | $38.58 | $204K | 363,945 |
| 2023-01-03 | O'Brien Patrick COO and General Counsel | Sale | −300 | $39.55 | $12K | 363,645 |
| 2023-01-03 | O'Brien Patrick COO and General Counsel | Sale | −270 | $40.53 | $11K | 363,375 |
| 2023-01-03 | Hamilton James C Chief Discovery/Trans Medicine | Sale | −1,194 | $37.46 | $45K | 154,431 |
| 2023-01-03 | Hamilton James C Chief Discovery/Trans Medicine | Sale | −2,837 | $38.53 | $109K | 151,594 |
| 2023-01-03 | Hamilton James C Chief Discovery/Trans Medicine | Sale | −300 | $39.74 | $12K | 151,294 |
| 2023-01-03 | Hamilton James C Chief Discovery/Trans Medicine | Sale | −136 | $40.54 | $6K | 151,158 |
| 2023-01-03 | Hamilton James C Chief Discovery/Trans Medicine | Sale | −1,642 | $37.49 | $62K | 149,516 |
| 2023-01-03 | Hamilton James C Chief Discovery/Trans Medicine | Sale | −3,682 | $38.52 | $142K | 145,834 |
| 2023-01-03 | Hamilton James C Chief Discovery/Trans Medicine | Sale | −300 | $39.56 | $12K | 145,534 |
| 2023-01-03 | Hamilton James C Chief Discovery/Trans Medicine | Sale | −247 | $40.52 | $10K | 145,287 |
Page 13 of 38 · 752 trades